Report cover image

Bioprocess Analyzers Market

Publisher Global Market Insights
Published Nov 05, 2024
Length 108 Pages
SKU # GMI19407226

Description

Bioprocess Analyzers Market


The Global Bioprocess Analyzers Market was valued at approximately USD 2 billion in 2023 and is projected to grow at a CAGR of 11.5% from 2024 to 2032. Bioprocess analyzers are essential tools used to monitor and optimize bioprocesses, which involve the use of living cells or their components to produce products such as biopharmaceuticals, biofuels, and other biotechnology-driven goods. These analyzers help improve the quality, efficiency, and control of biotechnological processes, especially in biologics production.

The ongoing advancements in biotechnology have led to the development of more sophisticated and automated bioprocess analyzers, further fueling market growth. Additionally, the growing demand for biosimilars, owing to their cost-efficiency compared to biologics, is a significant market growth driver. Government support and funding also foster innovation in this sector, underscoring the increasing importance of these instruments in the biopharmaceutical industry.

Based on analysis type, concentration detection emerged as the leading segment, generating USD 1.1 billion in revenue in 2023, with expectations for continued growth at a CAGR of 11.6%. Biologics production, including monoclonal antibodies and vaccines, relies on accurate measurements of critical parameters such as proteins, metabolites, and cell densities. This drives the demand for analyzers that can ensure consistent product quality and regulatory compliance.

By application, the market is divided into antibiotics, recombinant proteins, biosimilars, and other bioproducts. The antibiotics segment accounted for a significant 30.8% market share in 2023 and is anticipated to grow at a 10.2% CAGR over the forecast period. Antibiotic production involves intricate microbial fermentation processes that require precise environmental control. Bioprocess analyzers, equipped with advanced sensors, help monitor and maintain optimal fermentation conditions, such as oxygen levels, nutrient feed, and temperature, ultimately enhancing production efficiency.

In terms of regional growth, the North American bioprocess analyzers market is expected to reach USD 2 billion by 2032. The U.S. led the regional market in 2023, with a revenue share of USD 712.7 million. The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is driving the demand for biologics and personalized medicines. This, in turn, is boosting the need for bioprocess analyzers to improve production processes and maintain regulatory compliance in the development of these advanced therapies.

Table of Contents

108 Pages
Chapter 1 Methodology
1.1 Market segmentation
1.2 Market definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Company share analysis
1.4.2 Approach 2: Segmental analysis
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis, 2021 - 2032
2.2 By product trends
2.3 Analysis type trends
2.4 Application trends
2.5 End-use trends
2.6 Regional trends
Chapter 3 Bioprocess Analyzers Market Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for biopharmaceutical products
3.2.1.2 Advancements in biotechnology and bioprocessing
3.2.1.3 Increasing demand for biosimilars
3.2.1.4 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments
3.2.2.2 Complexity and technical expertise
3.3.1 By product
3.3.1 By analysis type
3.3.2 By application
3.3.3 By end-use
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.4.3 Asia Pacific
3.5 Technology landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Sartorius AG
4.1.2 F. Hoffmann-La Roche Ltd.
4.1.3 Danaher Corporation
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategy outlook matrix
Chapter 5 Bioprocess Analyzers Market, By Type
5.1 Instruments
5.2 Consumables & accessories
Chapter 6 Bioprocess Analyzers Market, By Analysis Type
6.1 Substrate analysis
6.2 Metabolite analysis
6.3 Concentration detection
Chapter 7 Bioprocess Analyzers Market, By Application
7.1 Antibiotics
7.2 Recombinant proteins
7.3 Biosimilars
7.4 Other applications
Chapter 8 Bioprocess Analyzers Market, By End-use
8.1 Biopharmaceutical companies
8.2 CROs & CMOs
8.3 Research & academic institutes
8.4 Other end-users
Chapter 9 Bioprocess Analyzers Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profile
10.1 4BioCell GmbH & Co. KG
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.4 Product landscape
10.1.1 SWOT analysis
10.2 Agilent Technologies, Inc.
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.2.4 Product landscape
10.2.5 SWOT analysis
10.3 Danaher Corporation
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.3.4 Product landscape
10.3.5 Strategic outlook
10.3.6 SWOT analysis
10.4 Endress+Hauser Group Services AG
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.4.4 Product landscape
10.4.5 SWOT analysis
10.5 Eppendorf AG
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2023 - 2020 (USD Million)
10.5.4 Product landscape
10.5.5 SWOT analysis
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Global overview
10.6.2 Business overview
10.6.3 Financial data
10.6.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.6.4 Product landscape
10.6.5 SWOT analysis
10.7 Nova Biomedical
10.7.1 Global overview
10.7.2 Business overview
10.7.3 Financial data
10.7.4 Product landscape
10.7.5 Strategic outlook
10.7.6 SWOT analysis
10.8 Randox Laboratories Ltd.
10.8.1 Global overview
10.8.2 Business overview
10.8.3 Financial data
10.8.4 Product landscape
10.8.5 SWOT analysis
10.9 Sartorius AG
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.9.4 Product landscape
10.9.5 Strategic outlook
10.9.6 SWOT analysis
10.10 Solida Biotech GmBH
10.10.1 Global overview
10.10.2 Business overview
10.10.3 Financial data
10.10.4 Product landscape
10.10.5 SWOT analysis
10.11 SYSBIOTECH GmbH
10.11.1 Global overview
10.11.2 Business overview
10.11.3 Financial data
10.11.4 Product landscape
10.11.5 SWOT analysis
10.12 Thermo Fisher Scientific, Inc.
10.12.1 Global overview
10.12.2 Business overview
10.12.3 Financial data
10.12.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.12.4 Product landscape
10.12.5 SWOT analysis
10.13 Xylem Inc.
10.13.1 Global overview
10.13.2 Business overview
10.13.3 Financial data
10.13.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.13.4 Product landscape
10.13.5 SWOT analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us